✦ LIBER ✦

Characteristics of indolent non-hodgkin lymphoma in patients with type 1 human immunodeficiency virus infection

✍ Scribed by Alexandra M. Levine; Saeed Sadeghi; Byron Espina; Anil Tulpule; Bharat Nathwani

Publisher: John Wiley and Sons
Year: 2002
Tongue: English
Weight: 82 KB
Volume: 94
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.10368

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Therapy-related leukemia in patients wit

✍ Jed A. Katzel; Sanford J. Kempin; Portia Lagmay-Fuentes; William A. Cook; Freder 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 254 KB 👁 2 views

Hodgkin disease developing in patients i

Hodgkin disease developing in patients infected by human immunodeficiency virus results in clinical features and a prognosis similar to those in patients with human immunodeficiency virus-related non-Hodgkin lymphoma

✍ Alessandro Re; Salvatore Casari; Chiara Cattaneo; Fabio Facchetti; GianPiero Cad 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 2 views

Prognostic factors after non-Hodgkin lym

Prognostic factors after non-Hodgkin lymphoma in patients infected with the human immunodeficiency virus : Aquitaine cohort, France, 1986–1997

✍ Frantz Thiessard; Philippe Morlat; Catherine Marimoutou; Eric Labouyrie; Jean-Ma 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 2 views

## BACKGROUND. The prognosis for survival of patients infected with the human immunodeficiency virus (HIV) who develop non-Hodgkin lymphoma (NHL) usually is considered to be poor. To the authors' knowledge the impact of highly active antiretroviral therapy, recently introduced in HIV disease case m

Intensive sequential chemotherapy with h

Intensive sequential chemotherapy with hematopoietic growth factor support for non-Hodgkin lymphoma in patients infected with the human immunodeficiency virus

✍ Régis T. Costello; Hacène Zerazhi; Aude Charbonnier; Jean-Marc Schiano de Colell 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

## Abstract ## BACKGROUND Optimal treatment of human immunodeficiency virus (HIV)‐associated non‐Hodgkin lymphoma (NHL) has yet to be defined, because chemotherapy could exacerbate immunodeficiency, with subsequent adverse effects for patients. ## METHODS The authors investigated the feasibility

Risk of non-Hodgkin's lymphoma in patien

Risk of non-Hodgkin's lymphoma in patients with hepatitis C virus infection

✍ Masahiko Ohsawa; Norihisa Shingu; Hideaki Miwa; Harumasa Yoshihara; Mitsuhiko Ku 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 59 KB 👁 2 views

Hepatitis C virus (HCV) has been suggested to play an etiological role in the development of B-cell non-Hodgkin's lymphoma (NHL) in Italy. However, another study in Scotland questioned increased risk of development of NHL in patients with chronic HCV infection. A total of 2,162 patients admitted to

Patterns of central nervous system recur

Patterns of central nervous system recurrence in patients with systemic human immunodeficiency virus-associated non-Hodgkin lymphoma

✍ Jigna Desai; Robin J. Mitnick; David H. Henry; Josefina Llena; Joseph A. Sparano 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 3 views

BACKGROUND. Central nervous system involvement is a common manifestation of non-Hodgkin lymphoma (NHL) in human immunodeficiency virus (HIV)-infected individuals. The purpose of this study was to review the frequency and pattern of neurologic manifestation of lymphoma in a cohort of HIV-infected ind